Drugs / valnoctamide
valnoctamide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00140179 | Sep 2004 → May 2008 | manic bipolar affective disorder, schizoaffective bipolar disorder | Beersheva Mental Health Center | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | valnoctamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00140179 ↗ |
| Known as | Axiquel | “It was marketed in the USA as Axiquel by McNeil in the 1970's.” NCT00140179 ↗ |
| Known as | MCN-X-181 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1075733 ↗ |
| Known as | Nirvanil | “It has been marketed as an anxiolytic and sedative in several European countries (as Nirvanil) including Italy, Holland and Switzerland but has not actively been promoted as an...” NCT00140179 ↗ |
| Known as | NSC-32363 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1075733 ↗ |
| Known as | NSC-34092 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1075733 ↗ |
| Known as | Valnoctamida | ChEMBL registry synonym — accepted as the source's own label CHEMBL1075733 ↗ |
| Modality | Small molecule | — CHEMBL1075733 ↗ |